ConductScience.org, home

Paper3977452

Thin (less than or equal to 1 mm) melanomas of the extremities are biologically favorable lesions not influenced by regression.

Wanebo HJ and 2 others. Ann Surg, 1985. Cited by 36 papers, by iCite.

Cite this record

ConductScience Library. Thin (less than or equal to 1 mm) melanomas of the extremities are biologically favorable lesions not influenced by regression. Papers, record 3977452. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3977452

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Thin (less than or equal to 1 mm) melanomas of the extremities are biologically favorable lesions not influenced by regression.
PubMed
Journal
Ann Surg
PubMed
Year
1985
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
36
iCite
Relative citation ratio, by iCite
1.7
iCite
Revised in PubMed
2023-02-08
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wanebo HJH J
2Cooper PHP H
3Hagar RWR W

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MelanomaMajor topic
Skin NeoplasmsMajor topic
Adult
Aged
Extremities
Female
Humans
Male
Middle Aged
Neoplasm Regression, Spontaneous

Source PubMed

Download CSV of topics

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15844157Spontaneous regression of primary malignant melanomas with regional metastases.Cancer1965https://conductscience.org/library/papers/5844157PubMed
26692315Conservative surgical management of superficially invasive cutaneous melanoma.Cancer1984https://conductscience.org/library/papers/6692315PubMed
34423522Tumor thickness and lymphocytic infiltration in malignant melanoma of the head and neck.Am J Surg1974https://conductscience.org/library/papers/4423522PubMed
41111935Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage).Cancer1975https://conductscience.org/library/papers/1111935PubMed
51190862Tumor thickness, level of invasion and node dissection in stage I cutaneous melanoma.Ann Surg1975https://conductscience.org/library/papers/1190862PubMed
6719608The regressing thin malignant melanoma: a distinctive lesion with metastatic potential.Cancer1978https://conductscience.org/library/papers/719608PubMed
7761159On the prognostic importance of white depressed areas in the primary lesion of superficial spreading melanoma.Cancer1979https://conductscience.org/library/papers/761159PubMed
8427730Tumor thickness as a guide to surgical management of clinical stage I melanoma patients.Cancer1979https://conductscience.org/library/papers/427730PubMed
9462379A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma.Surgery1979https://conductscience.org/library/papers/462379PubMed
10488922Prognostic significance of the histological features of malignant melanoma.Histopathology1979https://conductscience.org/library/papers/488922PubMed
117427045Tumour thickness and the site and time of first recurrence in cutaneous malignant melanoma (stage I).Br J Surg1980https://conductscience.org/library/papers/7427045PubMed
127439222Stage I melanoma of the skin: the problem of resection margins. W.H.O. Collaborating Centres for Evaluation of Methods of Diagnosis and Treatment of Melanoma.Eur J Cancer (1965)1980https://conductscience.org/library/papers/7439222PubMed
137212806A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent disease.Ann Surg1981https://conductscience.org/library/papers/7212806PubMed
147221889A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent disease.Surgery1981https://conductscience.org/library/papers/7221889PubMed
157226105Changes in clinical presentation and management of malignant melanoma.Cancer1981https://conductscience.org/library/papers/7226105PubMed
167284966Stage I melanoma of the skin: evaluation of prognosis according to histologic characteristics.Cancer1981https://conductscience.org/library/papers/7284966PubMed
177290125The natural break points for primary-tumor thickness in clinical Stage I melanoma.N Engl J Med1981https://conductscience.org/library/papers/7290125PubMed
187055381Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesions.Ann Surg1982https://conductscience.org/library/papers/7055381PubMed
197057847Narrower margins for clinical stage I malignant melanoma.N Engl J Med1982https://conductscience.org/library/papers/7057847PubMed
207074555Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities.Cancer1982https://conductscience.org/library/papers/7074555PubMed

See all 24 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.

PMIDTitleJournalYearIn PapersSource
28240749Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance.Lab Invest2017https://conductscience.org/library/papers/28240749PubMed
24281039Biology of human cutaneous melanoma.Cancers (Basel)2010https://conductscience.org/library/papers/24281039PubMed
22610274Outcome of sentinel lymph node biopsy and prognostic implications of regression in thin malignant melanoma.Melanoma Res2012https://conductscience.org/library/papers/22610274PubMed
17602225Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma.Cancer Immunol Immunother2008https://conductscience.org/library/papers/17602225PubMed
1561799Cutaneous melanomas exhibiting unusual biologic behavior.World J Surg1992https://conductscience.org/library/papers/1561799PubMed
1549899The significance of inflammation and regression in melanoma.Virchows Arch A Pathol Anat Histopathol1992https://conductscience.org/library/papers/1549899PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3977452

GET https://conductscience.org/api/papers/v1/3977452/references?page=2